Compare Medtronic PLC (MDT) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Wolfspeed Inc — how do they compare? Medtronic PLC trades at $88.79 (market cap $112.24B), while Wolfspeed Inc trades at $30.29 (market cap $1.64B). The key difference: Medtronic PLC is far larger — about 68.4× Wolfspeed Inc's market cap, and Medtronic PLC pays a 3.28% dividend while Wolfspeed Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Wolfspeed Inc for 19 Days on average.
| MDT | WOLF | |
|---|---|---|
Market Cap | $112.24B | $1.64B |
Volume | 105,663,236 | 22,772,687 |
Sector | Health | Technology |
52-Week High | $105.35 | $73.68 |
52-Week Low | $73.75 | $14.80 |
Typical Hold Time | 63 Days | 19 Days |
Enterprise Value | $131.58B | $2.35B |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
Wolfspeed (WOLF) trades at $30.62, down 2.39% today, with a bullish technical signal supported by moving averages. The company shows improving quarterly earnings performance with recent beats, though 2025 fundamentals reveal significant losses (-$1.61B net income) and negative margins. Recent news highlights expansion of 200mm silicon carbide substrates and AI infrastructure exposure. Analyst consensus price target sits at $54.32, representing 77% upside potential from current levels.
Wolfspeed presents a high-risk, high-reward opportunity with strong analyst upside potential but substantial fundamental challenges. The company's path to profitability depends on successful execution of its silicon carbide technology roadmap and achieving breakeven revenue targets. Near-term volatility is expected given ongoing operational challenges and investor investigations, while long-term prospects hinge on AI infrastructure adoption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
